News Snapshot:
An Eli Lilly pharmaceutical manufacturing plant in Branchburg, New Jersey. The French medical charity Medecins Sans Frontieres said baricitinib can be a potential alternative to scarce monoclonal antibody treatments. © Reuters January 14, 2022 08:49 JST | Europe Copy Copied A World Health Organization (WHO) panel recommended use of two drugs by Eli Lilly, and GlaxoSmithKline and Vir Biotechnology for COVID-19 patients, adding treatment options as the fast-spreading Omicron variant renders many ineffective. Read Next